Finding · criterion S8

Warning letters across the field, and what happened next

57 of the 586 records in the ledger disclose an FDA warning letter, 57 letters in all. 57 of the 57 still trade. 0 have been halted by an FDA action. 0 of the 57 letters carry a close-out letter on the FDA index.

Criterion S8, enforcement status, records a letter and fails a seller only where an action halted the business. This piece reports the letters in aggregate: every one by number and date, what it alleges, how it was tied to the record, and what has happened since. It is not a list of flagged sellers. A letter is recorded on the seller record in full, and a record with a letter links, sorts and appears exactly as a record without one. The census below was run against Standard v1.1, on the date stated above, over every record in the ledger.

The number, with its denominator

Of the 586 records, 57 name at least one letter: Alan Meds, altRx, AM Rx, Belle, Bioverse, Bliv, Curex, CVS MinuteClinic, Direct Meds, Eden, Elevated Health, Fifty 410, Fitish, FitRx, Genesis Health, GoodGirlRx, Harper Meds, Healthon, Hers, Hims, Intimate Rose, Ivim Health, Joi and Blokes, Kin Meds, Lovely Meds, LumiMeds, Lyfe RX, Maximus, MaxLife, Measured, MEDVi, Mint Med, MyStart Health, NativeMed, NewSelf, Nexlife, OrderlyMeds, Pinnacle Peptides, Premium Health, Prime Peptides, Pure Rawz, Refills, Remedy Meds, RoenRx, SkinnyRx, Sprout Health, Strut Health, Swiss Chems, TRYM Health, Tuyo Health, VivioMD, Walgreens Weight Management, WeightCare, Xcel Peptides, Zappy Health, Zealthy, Zeuss. S8 records 0 failures across the 586 records, because no FDA action recorded here has halted a business.

What a warning letter is

The Food and Drug Administration describes its own instrument plainly. A warning letter “identifies the concern(s), such as poor manufacturing practices, problems with claims for what a product can do, or incorrect directions for use,” and “provides an opportunity for the company or individual to address FDA's concerns and requests a response with a certain timeframe.” Each of the 57 letters below asks for a written response within fifteen working days and states that failure to address the violations may result in legal action, including seizure and injunction. Seizure and injunction are the actions S8 fails on. The letter is the notice that precedes them, and it is not one of them.

FDA also publishes a close-out letter where it has evaluated a company's corrective actions and found them adequate, and states that a close-out “will not be issued based on representations that some action will or has been taken.” The index reserves a column for it. As of September 2026 the index held 3,677 letters, and 417 of them carried a close-out letter in that column, so the column is populated and an empty cell is a reading rather than a gap. For the 57 letters below the cell is empty in 57 cases.

The letters, by number

Each letter has its own page on this site, carrying the header as filed, the website the agency states it reviewed, the sections cited, the claims quoted from the seller's pages, and the attribution test. The index of those pages lists all 57 in issue order.

Every letter is quoted from its own page on fda.gov, as it stood on the date stated beneath the sources. The addressee and address are copied from the letter header; the subject is the one the index files it under; the allegation is the letter's own operative sentence, paraphrased; and the list beneath the table states the test that ties each letter to its ledger record. A name resemblance is never the test.

What each letter alleges, in one sentence, and the test that ties it to the record it is filed on.

Two kinds of letter

The index files the 57 letters under 4 subjects: 33 under “False & Misleading Claims/Misbranded (Telehealth)”; 17 under “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”; 6 under “Unapproved New Drugs/Misbranded”; 1 under “Unapproved New Drugs”. The telehealth subjects turn on sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, which concern labeling and the advertising of compounded drugs. The research-vendor subject turns on sections 505(a) and 301(d), which concern an unapproved new drug intended for human use. A labeling citation and an unapproved-drug citation are different allegations, and the subject line says which one a reader is looking at.

17 of the letters above were issued on a single day, to Hims & Hers Health, Inc. dba Hims, Hims & Hers Health, Inc. dba Hers, the operating company of Direct Meds dba DirectMeds, Sprout Health Partners LLC dba Sprout Health, FitRX, LLC dba Zealthy, Remedy Meds, Elevate Your Wellness LLC, dba Elevated, Healthon Inc. dba Healthon, Bioverse, Inc. dba Bioverse, Lovely Meds, Inc. dba Lovely Meds, Lumimeds, Tuyo Health, Inc. dba Tuyo Health, Curex, Intimate Rose, Lyfe Rx, Matthew Stern, CEO MyStart Health LLC., TRYM Health, Inc. dba TRYM Health, and each names the month before as the month its website was reviewed. The index records 69 letters carrying that one issue date, among them letters to Eli Lilly and Company, letter 716462 and Novo Nordisk Inc., letter 716495, the manufacturers of the brand drugs the telehealth letters compare against. A letter issued in that wave sits in the same database, on the same page, with the same date, as a letter to the manufacturer of the approved product.

2 more share another single issue date, to Walgreens Boots Alliance, Inc., CVS Health. 3 more share another single issue date, to Swisschems, Prime Vitality, Inc. dba Prime Peptides, Xcel Research LLC. 20 more share another single issue date, to Strut Health, LLC dba Strut, Ivim Services LLC dba Ivim, Good Girl LLC dba GoodGirlRX, Lean Rx, Inc. dba SkinnyRx, Kare Solutions, LLC dba Zappy, Weightless Medical LLC dba WeightCare, Kin Meds, Alan Health Technologies Inc. dba Alan, Belle Health LLC dba Belle, Better Health Labs, Inc. dba Measured, Genesis Health International Inc. dba Genesis, Bliv Wellness LLC dba Bliv, Aspen Aesthetics dba Fifty 410, MaxLife Technologies Inc. dba Maxlife, Premium Health Management Inc. dba Premium Health, Refills Health, LLC dba Refills Health, NewSelf Limited dba NewSelf, Zeuss LLC dba Zeuss, MEDVi, LLC dba MEDVi, FitRX, LLC dba FitRx. 13 more share another single issue date, to Eden Health International Inc. dba Eden, Trinity HealthCare Supply, LLC dba altRx, OrderlyMeds LLC dba OrderlyMeds, Maximus Health, Inc. dba Maximus, Joi and Blokes dba Joi + Blokes, FITISH, NativeMed LLC dba NativeMed, Nexus Health Solutions LLC dba Harper Meds, Roen Health, Inc. dba RoenRx, Glow Medispa, LLC dba Mint Med, Nexlife Inc. dba Nexlife, FitRX, LLC dba AM RX, VivioMD Group LLC dba VivioMD.

What the letters allege

Two allegations recur across the telehealth letters. The first is a claim of sameness, that a compounded product has the same active ingredient as Ozempic, Wegovy, Mounjaro or Zepbound, which FDA reads as implying equivalence to an approved drug. It appears in 30 letters, naming 30 companies: Hims, Hers, Direct Meds, Zealthy, Remedy Meds, Elevated Health, Healthon, Bioverse, Lovely Meds, LumiMeds, Tuyo Health, Curex, Intimate Rose, MyStart Health, TRYM Health, Strut Health, SkinnyRx, Zappy Health, Kin Meds, Measured, Genesis Health, Premium Health, Refills, NewSelf, MEDVi, Joi and Blokes, Fitish, NativeMed, Harper Meds, AM Rx. The second is a claim of authorship, that a pictured label names the seller as the compounder when a pharmacy the seller does not name did the compounding. It appears in 29 letters, naming 29 companies: Strut Health, Ivim Health, GoodGirlRx, WeightCare, Kin Meds, Alan Meds, Belle, Measured, Genesis Health, Bliv, Fifty 410, MaxLife, Premium Health, Refills, NewSelf, Zeuss, MEDVi, FitRx, Eden, altRx, OrderlyMeds, Fitish, NativeMed, Harper Meds, RoenRx, Mint Med, Nexlife, AM Rx, VivioMD.

The second pattern is the regulator asking the question criterion S3, pharmacy identification, asks. Each of those letters closes by requesting that the company identify the entities that produce the compounded products offered on its website. 3 of them carry a further allegation: the site described its sources as FDA-licensed facilities, and FDA states that it grants no such designation to a pharmacy or an outsourcing facility. That appears in the letters to Eden, OrderlyMeds, Harper Meds. The 7 research-vendor letters are different in kind: they allege that products labeled for research were, on the evidence of the seller's own product pages and social media, intended for human use. They name Walgreens Weight Management, CVS MinuteClinic, Swiss Chems, Prime Peptides, Xcel Peptides, Pure Rawz, Pinnacle Peptides.

The cross-tabulation of that second pattern against S3 →

What happened next

Every one of the 57 lettered records states, in its S8 basis, that the seller still trades. No record names an injunction, a consent decree, a seizure or a closure. No letter carries a close-out letter on the index, so no allegation is recorded as resolved either. A letter that has been neither closed out nor followed by an action is the ordinary state of a warning letter, and it is what every letter in this ledger is in.

How S8 records this

Under the first version of the Standard a letter failed the criterion. Version 1.1 changed that, and the changelog names the dispositions that moved: S8 re-scoped from Enforcement record to Enforcement status. A warning letter is now recorded and dated on the seller record rather than failing the criterion; the failing disposition is reserved for an action that halts the business, such as an injunction, consent decree, or seizure. Every letter recorded in this ledger cites a labeling or advertising provision, or an unapproved-drug provision, and none records an action that halted a business; the count and the sections cited are on the warning-letter pages. Two dispositions changed under this revision: Direct Meds and Swiss Chems. A rule that treated every letter as a failure would tell a reader that a company under a labeling citation and a company shut down by a court are the same thing. They are not, and the ledger now records the difference.

The full roster

Every record in the ledger, with its S8 disposition and the basis recorded against it. A record with no letter comes from a screen of the full warning-letter index that also finds a known control letter, so an absence there is a real absence. The method page sets out the screen.

Sources

All 61 sources below read September 2026.

• FDA warning letter 663404 to Walgreens Boots Alliance, Inc.
• FDA warning letter 663246 to CVS Health
• FDA warning letter 695663 to Swisschems
• FDA warning letter 695156 to Prime Vitality, Inc. dba Prime Peptides
• FDA warning letter 694608 to Xcel Research LLC
• FDA warning letter 715218 to PureRawz
• FDA warning letter 716567 to Hims & Hers Health, Inc. dba Hims
• FDA warning letter 716825 to Hims & Hers Health, Inc. dba Hers
• FDA warning letter 716822 to the operating company of Direct Meds dba DirectMeds
• FDA warning letter 715879 to Sprout Health Partners LLC dba Sprout Health
• FDA warning letter 716501 to FitRX, LLC dba Zealthy
• FDA warning letter 716830 to Remedy Meds
• FDA warning letter 719811 to Elevate Your Wellness LLC, dba Elevated
• FDA warning letter 719809 to Healthon Inc. dba Healthon
• FDA warning letter 716508 to Bioverse, Inc. dba Bioverse
• FDA warning letter 716829 to Lovely Meds, Inc. dba Lovely Meds
• FDA warning letter 716510 to Lumimeds
• FDA warning letter 716502 to Tuyo Health, Inc. dba Tuyo Health
• FDA warning letter 716821 to Curex
• FDA warning letter 716458 to Intimate Rose
• FDA warning letter without a number to Lyfe Rx
• FDA warning letter 714755 to Matthew Stern, CEO MyStart Health LLC.
• FDA warning letter 716699 to TRYM Health, Inc. dba TRYM Health
• FDA warning letter 719337 to Pinnacle Professional Research dba Pinnacle Peptides
• FDA warning letter 721448 to Strut Health, LLC dba Strut
• FDA warning letter 721816 to Ivim Services LLC dba Ivim
• FDA warning letter 721449 to Good Girl LLC dba GoodGirlRX
• FDA warning letter 717989 to Lean Rx, Inc. dba SkinnyRx
• FDA warning letter 717991 to Kare Solutions, LLC dba Zappy
• FDA warning letter 721478 to Weightless Medical LLC dba WeightCare
• FDA warning letter 721450 to Kin Meds
• FDA warning letter 721814 to Alan Health Technologies Inc. dba Alan
• FDA warning letter 721795 to Belle Health LLC dba Belle
• FDA warning letter 721454 to Better Health Labs, Inc. dba Measured
• FDA warning letter 721451 to Genesis Health International Inc. dba Genesis
• FDA warning letter 721479 to Bliv Wellness LLC dba Bliv
• FDA warning letter 721481 to Aspen Aesthetics dba Fifty 410
• FDA warning letter 721453 to MaxLife Technologies Inc. dba Maxlife
• FDA warning letter 721474 to Premium Health Management Inc. dba Premium Health
• FDA warning letter 721475 to Refills Health, LLC dba Refills Health
• FDA warning letter 721472 to NewSelf Limited dba NewSelf
• FDA warning letter 717985 to Zeuss LLC dba Zeuss
• FDA warning letter 721455 to MEDVi, LLC dba MEDVi
• FDA warning letter 717987 to FitRX, LLC dba FitRx
• FDA warning letter 728279 to Eden Health International Inc. dba Eden
• FDA warning letter 728236 to Trinity HealthCare Supply, LLC dba altRx
• FDA warning letter 728291 to OrderlyMeds LLC dba OrderlyMeds
• FDA warning letter 730095 to Maximus Health, Inc. dba Maximus
• FDA warning letter 728283 to Joi and Blokes dba Joi + Blokes
• FDA warning letter 728280 to FITISH
• FDA warning letter 728287 to NativeMed LLC dba NativeMed
• FDA warning letter 728281 to Nexus Health Solutions LLC dba Harper Meds
• FDA warning letter 728293 to Roen Health, Inc. dba RoenRx
• FDA warning letter 730390 to Glow Medispa, LLC dba Mint Med
• FDA warning letter 730096 to Nexlife Inc. dba Nexlife
• FDA warning letter 728275 to FitRX, LLC dba AM RX
• FDA warning letter 728295 to VivioMD Group LLC dba VivioMD
• FDA warning letter 716462 to Eli Lilly and Company, issued the same day
• FDA warning letter 716495 to Novo Nordisk Inc., issued the same day
• FDA, About Warning and Close-Out Letters
• FDA warning letter index, every letter the agency lists

Counts are generated from the ledger at build time, so this page cannot drift from the records it summarizes. Method and null semantics: how checks are performed. This page ranks nothing, recommends nothing, and carries no partner link.

Related findings

All 32 findings →